Test Price
2,800 AED✅ Home Collection Available
COL9A3 Gene Epiphyseal Dysplasia, Multiple, Type 3 Genetic Test in UAE | 2800 AED
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Next‑Generation Sequencing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature‑Controlled Cold‑Chain Home Collection (daily 8 AM – 11 PM).
- Clinical Guidance: Telephonic Post‑Test Clinical Interpretation Support from DHA‑licensed specialists.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The COL9A3 gene test uses Next‑Generation Sequencing (NGS) to detect pathogenic variants responsible for Multiple Epiphyseal Dysplasia Type 3, a disorder with skeletal, dermatological, and immunological features. This analysis provides definitive diagnosis for targeted management.
| Feature | Our COL9A3 NGS Test | Closest Alternative (Whole‑Exome Sequencing) |
|---|---|---|
| Diagnostic Precision | 99.9% targeted single‑gene coverage | ~95% exome coverage with incidental findings |
| Methodology | Deep NGS with bioinformatic variant prioritisation | Broad NGS capture; requires orthogonal validation |
| Turnaround Time | 3 to 4 weeks | 6‑10 weeks |
| Cost (UAE) | 2,800 AED | 5,500–8,000 AED |
| Clinical Focus | Definitive diagnosis of MED type 3 | Broad screening with many secondary findings |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics, I understand the emotional weight of genetic testing. This COL9A3 analysis offers a definitive window into epiphyseal dysplasia, but every result must be correlated with your full clinical picture. Please maintain your current treatment and discuss any changes only with your personal physician.” — Lina Osama Zaki Quteineh (DHA Registration ID: 9294403)
Advisory: Medication Safety
⚠️ Do not discontinue any prescribed medication without first consulting your doctor. Genetic testing results may influence future management, but immediate changes require physician oversight.
Exclusion Criteria & Emergency Red Flags
- Exclusion: Acute infection within 14 days, recent blood transfusion (≤4 weeks), or inability to provide informed consent.
- Exclusion (Minors): Must comply with guardian genetic counselling as per Federal Decree‑Law No. 4 of 2016 on Medical Liability.
- ER Red Flags: Sudden, severe joint swelling with fever, acute neurological deficits (suspected spinal cord compromise), or new‑onset skin bullae with rapid spread require immediate emergency evaluation.
Patient FAQ & Clinical Guidance
1. What exactly does the COL9A3 gene test detect and why is it ordered?
The COL9A3 gene test sequences your COL9A3 DNA to identify pathogenic mutations causing multiple epiphyseal dysplasia type 3, enabling precise diagnosis and personalized management planning.
2. How is the sample collected and what is the turnaround time?
A simple blood draw or a single drop of blood on an FTA card is collected at your home by ISO‑certified phlebotomists via VIP Mobile Phlebotomy (Temperature‑Controlled Cold‑Chain). Results delivered in 3–4 weeks.
3. Will my insurance cover the 2,800 AED cost?
Most UAE insurers cover genetic testing when medically necessary; our team verifies your policy within minutes via WhatsApp at +971 54 548 8731.
4. Can this test be done on a child?
Yes, with informed consent from a legal guardian and prior genetic counselling. The test is safe and requires a simple blood sample.
UAE Regulatory & Data Privacy Adherence
Data Protection: All genetic data is processed in compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields.
Medical Liability: Patient safety and consent procedures follow Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Accreditations: Laboratory certified ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139). DHA Facility License: 1143.
Home Collection Hotline: +971 54 548 8731 (8 AM – 11 PM daily).
Relevant Specialists: Clinical Geneticist · Orthopaedic Surgeon · Dermatologist
Clinical & Logistical Metadata
| Test Name | COL9A3 Gene Epiphyseal Dysplasia, Multiple, Type 3 Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Peripheral whole blood or FTA card (VIP Mobile Phlebotomy available) |
| Methodology Used | Next‑Generation Sequencing (NGS) with bioinformatic variant prioritisation |
| ICD-10-CM Code | Q78.8 (Other specified osteochondrodysplasia) |
| LOINC Code | 49842-2 (COL9A3 gene mutation analysis) |
| DHA Facility License & Laboratory Address | License No. 1143 – Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE (DNA Labs UAE) |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians